-
EP0312906
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0312906
| EP0312906 - Novel sulfonamide derivatives [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.05.1993 Database last updated on 02.09.2024 | Most recent event Tooltip | 17.05.1993 | Application deemed to be withdrawn | published on 07.07.1993 [1993/27] | Applicant(s) | For all designated states ONO PHARMACEUTICAL CO., LTD. No. 14, Doshomachi 2-chome Higashi-ku Osaka-shi Osaka / JP | [N/P] |
| Former [1989/17] | For all designated states ONO PHARMACEUTICAL CO., LTD. No. 14, Doshomachi 2-chome Higashi-ku Osaka-shi Osaka / JP | Inventor(s) | 01 /
Arai, Yoshinobu 5-8-505, Wakayamadai 1 Shimamoto-cho Mishima-gun Osaka / JP | 02 /
Hamanaka, Nobuyuki 11-38, Hiroshiki Ohyamazaki-cho Otokuni-gun Kyoto / JP | 03 /
Miyazaki, Tohru Dainiminasehaitsu 501 2-6, Minase 2 Shimamoto-cho Mishima-gun Osaka / JP | [1989/17] | Representative(s) | Henkel & Partner mbB Patentanwaltskanzlei, Rechtsanwaltskanzlei Maximiliansplatz 21 80333 München / DE | [N/P] |
| Former [1989/17] | Henkel, Feiler, Hänzel & Partner Möhlstrasse 37 D-81675 München / DE | Application number, filing date | 88116960.1 | 12.10.1988 | [1989/17] | Priority number, date | JP19870266501 | 23.10.1987 Original published format: JP 26650187 | JP19880094545 | 19.04.1988 Original published format: JP 9454588 | JP19880094546 | 19.04.1988 Original published format: JP 9454688 | JP19880197180 | 09.08.1988 Original published format: JP 19718088 | [1989/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0312906 | Date: | 26.04.1989 | Language: | EN | [1989/17] | Type: | A3 Search report | No.: | EP0312906 | Date: | 05.09.1990 | Language: | EN | [1990/36] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.07.1990 | Classification | IPC: | C07C177/00, C07C143/72, A61K31/557 | [1989/17] | CPC: |
C07C405/0091 (EP,US);
C07C311/20 (EP,US);
C07C2601/08 (EP,US);
C07C2602/42 (EP,US)
| Designated contracting states | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1989/17] | Title | German: | Sulfonamidderivate | [1989/17] | English: | Novel sulfonamide derivatives | [1989/17] | French: | Dérivés de sulfonamide | [1989/17] | File destroyed: | 12.06.1999 | Miscellaneous | EPB 1992/39: Teilanmeldung 92112017.6 eingereicht am 12/10/88 | EPB 1992/39: Divisional application 92112017.6 filed on 12/10/88 | EPB 1992/39: Demande divisionnaire 92112017.6 déposée le 12/10/88 | Examination procedure | 28.12.1990 | Examination requested [1991/10] | 13.03.1992 | Despatch of a communication from the examining division (Time limit: M04) | 08.07.1992 | Reply to a communication from the examining division | 03.09.1992 | Despatch of a communication from the examining division (Time limit: M04) | 14.01.1993 | Application deemed to be withdrawn, date of legal effect [1993/27] | 11.02.1993 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1993/27] | Divisional application(s) | EP92112017.6 / EP0516180 | EP92112113.3 / EP0516181 | Fees paid | Renewal fee | 12.10.1990 | Renewal fee patent year 03 | 10.10.1991 | Renewal fee patent year 04 | 09.10.1992 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]EP0226346 (SHIONOGI & CO [JP]); | [X]US4654357 (NAKANE MASAMI [US]) | [XP] - Taipei Conference on prostaglandin and Leukotriene Research, April 22-24, 1988, Vol. 19, pages 663-665, Advances in Prostaglandin, Thromboxane and Leukotriene Research, N. HAMANAKA: "Developments in TXA2 antagonists". |